| Sarah Dowdy, | |
|
508 E Three Notch St Ste 100, Andalusia, AL 36420-3128 | |
| (334) 362-2015 | |
| Not Available |
| Full Name | Sarah Dowdy |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 508 E Three Notch St Ste 100, Andalusia, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083284533 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 1-155137 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rural Urgent Care Llc | 8820305600 | 113 |
News Archive
A group of researchers based at the Papa Giovanni XXIII hospital in Italy have submitted evidence to suggest that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may adequately benefit from a single dose of mRNA vaccine, rather than requiring the current two-vaccine regimen.
In this New York Times opinion piece, Frank Smithuis, director of Medical Action Myanmar in Yangon, and Nick White, professor of tropical medicine at the Mahidol Oxford Tropical Medicine Research Unit in Bangkok, recount a brief history of the development of anti-malaria drugs and their contribution to "a significant global reduction in malaria" and note that this progress "is now threatened by the emergence of malaria parasites that are resistant to artemisinin on the Cambodia-Thailand border ..., the same place where chloroquine resistance emerged 50 years ago and spread across Asia and Africa to claim millions of lives."
For patients with inflammatory bowel disease, the possibility of taking a single pill to bring long-lasting relief might seem too good to be true. Scientists at the Lewis Katz School of Medicine at Temple University are on the brink of making that happen, thanks to a recent proof-of-concept study, in which the severity of a form of inflammatory bowel disease in mice was dramatically reduced with one oral dose of a protein isolated from a bacterial biofilm.
University of Alberta scientists have identified three biomarkers for detecting mild cognitive impairment and Alzheimer's disease in saliva samples. The research has promising results for application in a clinical setting.
› Verified 4 days ago
| Entity Name | Rural Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932586476 PECOS PAC ID: 8820305600 Enrollment ID: O20150910001722 |
News Archive
A group of researchers based at the Papa Giovanni XXIII hospital in Italy have submitted evidence to suggest that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may adequately benefit from a single dose of mRNA vaccine, rather than requiring the current two-vaccine regimen.
In this New York Times opinion piece, Frank Smithuis, director of Medical Action Myanmar in Yangon, and Nick White, professor of tropical medicine at the Mahidol Oxford Tropical Medicine Research Unit in Bangkok, recount a brief history of the development of anti-malaria drugs and their contribution to "a significant global reduction in malaria" and note that this progress "is now threatened by the emergence of malaria parasites that are resistant to artemisinin on the Cambodia-Thailand border ..., the same place where chloroquine resistance emerged 50 years ago and spread across Asia and Africa to claim millions of lives."
For patients with inflammatory bowel disease, the possibility of taking a single pill to bring long-lasting relief might seem too good to be true. Scientists at the Lewis Katz School of Medicine at Temple University are on the brink of making that happen, thanks to a recent proof-of-concept study, in which the severity of a form of inflammatory bowel disease in mice was dramatically reduced with one oral dose of a protein isolated from a bacterial biofilm.
University of Alberta scientists have identified three biomarkers for detecting mild cognitive impairment and Alzheimer's disease in saliva samples. The research has promising results for application in a clinical setting.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Dowdy, 1500 1st Ave N Unit 3, Birmingham, AL 35203-1866 Ph: () - | Sarah Dowdy, 508 E Three Notch St Ste 100, Andalusia, AL 36420-3128 Ph: (334) 362-2015 |
News Archive
A group of researchers based at the Papa Giovanni XXIII hospital in Italy have submitted evidence to suggest that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may adequately benefit from a single dose of mRNA vaccine, rather than requiring the current two-vaccine regimen.
In this New York Times opinion piece, Frank Smithuis, director of Medical Action Myanmar in Yangon, and Nick White, professor of tropical medicine at the Mahidol Oxford Tropical Medicine Research Unit in Bangkok, recount a brief history of the development of anti-malaria drugs and their contribution to "a significant global reduction in malaria" and note that this progress "is now threatened by the emergence of malaria parasites that are resistant to artemisinin on the Cambodia-Thailand border ..., the same place where chloroquine resistance emerged 50 years ago and spread across Asia and Africa to claim millions of lives."
For patients with inflammatory bowel disease, the possibility of taking a single pill to bring long-lasting relief might seem too good to be true. Scientists at the Lewis Katz School of Medicine at Temple University are on the brink of making that happen, thanks to a recent proof-of-concept study, in which the severity of a form of inflammatory bowel disease in mice was dramatically reduced with one oral dose of a protein isolated from a bacterial biofilm.
University of Alberta scientists have identified three biomarkers for detecting mild cognitive impairment and Alzheimer's disease in saliva samples. The research has promising results for application in a clinical setting.
› Verified 4 days ago
Heide Sue Price, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 215 Medical Park Dr Ste 1, Andalusia, AL 36420 Phone: 334-222-4327 Fax: 334-222-4333 | |
Mrs. Candace W Cassady, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 104 Medical Park Dr., Andalusia, AL 36420 Phone: 334-222-2562 Fax: 334-222-2725 | |
Marc Chatman, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 849 S Three Notch St, Andalusia, AL 36420 Phone: 334-222-8466 | |
Jacqueline Hope Veasey, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 614 W Bypass, Andalusia, AL 36420 Phone: 334-222-0119 Fax: 334-427-9522 | |
Ricky L Lewis, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 835 S Three Notch St, Andalusia, AL 36420 Phone: 334-222-8421 Fax: 334-222-1248 | |
Micalyn Kelley, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 109 Opp Ave, Andalusia, AL 36420 Phone: 850-444-4700 Fax: 850-444-7497 |